APD Air Products & Chemicals, Inc.
Industrial Inorganic Chemicals · NYSE · SEC CIK 2969 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.5%
TTM net income YoY-103.1%
TTM EPS YoY-103.0%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—
Margins
Gross margin32.1%
Operating margin-4.7%
Net margin-0.4%
FCF margin-2.4%
EBITDA margin7.5%
Returns
ROE-0.3%
ROA-0.1%
ROIC (approx.)-3.6%
Asset turnover0.31x
Leverage & solvency
Liabilities / assets59.0%
Debt / equity0.00x
Current ratio1.08x
Interest coverage-2.68x
Cash quality & payout
Operating cash flow / net income-96.63x
Accruals ratio-11.2%
Payout ratio—
Capex / revenue38.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 |
|---|---|---|
| Income statement | ||
| Revenue | $12.04B | $12.10B |
| Cost of revenue | $8.26B | $8.17B |
| Gross profit | $3.78B | $3.93B |
| R&D expense | $96.30M | $100.20M |
| SG&A expense | $906.10M | $942.40M |
| Operating income | -$877.00M | $4.47B |
| Interest expense | $214.00M | $218.80M |
| Pretax income | -$440.70M | $4.82B |
| Income tax | -$94.30M | $944.90M |
| Net income | -$394.50M | $3.83B |
| EBITDA | $687.20M | $5.92B |
| EPS (basic) | -1.77 | 17.21 |
| EPS (diluted) | -1.77 | 17.18 |
| Dividends declared per share | 7.14 | 7.06 |
| Weighted avg. shares (diluted) | 222.70M | 222.80M |
| Balance sheet | ||
| Cash & equivalents | $1.86B | $2.98B |
| Short-term investments | $0 | $5.00M |
| Receivables | $1.90B | $1.82B |
| Inventory | $776.50M | $766.00M |
| Current assets | $5.83B | $6.36B |
| PP&E, net | $25.34B | $23.37B |
| Goodwill | $963.90M | $905.10M |
| Intangibles | $293.50M | $311.60M |
| Total assets | $41.06B | $39.57B |
| Current liabilities | $4.22B | $4.18B |
| Short-term debt | $34.70M | $83.50M |
| Total liabilities | $23.71B | $20.90B |
| Shareholders' equity | $15.02B | $17.04B |
| Shares outstanding | 222.59M | 222.37M |
| Cash flow statement | ||
| Operating cash flow | $3.26B | $3.65B |
| Capital expenditure | $7.02B | $6.80B |
| Free cash flow | -$3.77B | -$3.15B |
| Investing cash flow | -$7.17B | -$4.92B |
| Financing cash flow | $2.80B | $2.62B |
| Depreciation & amortization | $1.56B | $1.45B |
| Stock-based compensation | $76.40M | $61.80M |
| Dividends paid | $1.58B | $1.56B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.